Le role des centres de convention du diabete en Belgique.

Belgium; Diabetes Mellitus, Type 1/therapy; Diabetes Mellitus, Type 2/therapy; Hospitals; Humans; Inpatients; Interprofessional Relations; Patient Care Team; Patient Education as Topic; Physicians, Family

Abstract :

[en] We briefly present the modes of functioning of Diabetes Convention Centres in Belgium. In those hospital centres, patients with both type 1 or type 2 diabetes, treated by at least two insulin injections per day, benefit of an intensive educational programme by a multidisciplinary team and receive free of charge material for home blood glucose monitoring, in order to optimize diabetes management. The collaboration between convention centres and general practitioners should be reinforced (share-care), especially to improve the management of type 2 diabetic patients, who are increasingly treated with various insulin regimens.

Disciplines :

Endocrinology, metabolism & nutrition

Author, co-author :

Nobels, F.

Scheen, André ; Université de Liège - ULiège > Département des sciences cliniques > Diabétologie, nutrition et maladie métaboliques - Médecine interne générale

Language :

French

Title :

Le role des centres de convention du diabete en Belgique.

Alternative titles :

[en] The role of diabetes convention centres in Belgium

Publication date :

2005

Journal title :

Revue Médicale de Liège

ISSN :

0370-629X

eISSN :

2566-1566

Publisher :

Université de Liège. Revue Médicale de Liège, Liège, Belgium

Special issue title :

Le diabète sucré dans tous ses états

Volume :

Issue :

5-6

Pages :

619-23

Peer reviewed :

Peer reviewed

Additional URL :

http://www.rmlg.ulg.ac.be

Available on ORBi :

since 26 March 2009

Statistics

Number of views

493 (4 by ULiège)

Number of downloads

485 (4 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

Bibliography

Scheen AJ.- Comment j'explore ... le contrôle glycémique des patients diabétiques à domicile. Rev Med Liège, 1999, 54, 893-897.
Philips J-C, Radermecker RP.- L'insulinothérapie dans le diabète de type 1. Rev Med Liège, 2005, 60, 322-328.
Radermecker RP, Hermans MP, Legrand DA, Scheen AJ.- L'insulinothé rapie par pompe externe à perfusion continue d'insuline. Rev Med Liège, 2005, 60, 329-334.
Golay A, Lagger G, Chambouleyron M, Lasserre-Moutet A.- L'enseignement thérapeutique: application au patient diabétique. Rev Med Liège, 2005, 60, 599-603.
Lebrethon M-C, Philippart D, Rocour-Brumioul D, Bourguignon JP et al.- Le diabète de l'enfant et de l'adolescent. 1. Prise en charge par le Service Universitaire de Pédiatrie et la Cellule «Education- Diabète en Pédiatrie». Rev Med Liège, 2005, 60, 313-319.
Nobels F, Debacker N, Scheen AJ.- Initiative pour la Promotion de la Qualité et Epidémiologie du Diabète sucré (IPQED). Rev Med Liège, 2005, 60, 624-627.
Debacker N, Van Crombrugge P, Nobels F, Suetens C.- Initiatief voor Kwaliteitsbevordering en Epidemiologie bij Diabetes (IKED). Rapport 2001. IPH/EPI reports nr. 2002-030 (www.iph.fgov.be).
Debacker N, Nobels F, Van Crombrugge P, et al.- Initiatief voor Kwaliteitsbevordering en Epidemiologie bij Diabetes (IKED). Rapport 2002. IPH/EPI reports nr. 2003-023 (www.iph.fgov.be).
Diabetes Control and Complications Trial Research Group.- The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med, 1993, 329, 977-986
The UK Prospective Diabetes Study (UKPDS) Group.- Intensive blood-glucose control with sulphonyureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet, 1998, 352, 837-853.
Epidemiology of Diabetes Interventions and Complications Research Group.- Effect of intensive therapy on microvascular complications of type 1 diabetes. JAMA, 2002, 287, 2563-2569.
Gæde P, Vedel P, Larsen N, et al.- Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med, 2003, 348, 383-393.
Scheen AJ, Van Gaal LF.- Le diabète de type 2 au coeur du syndrome métabolique: plaidoyer pour une prise en charge globale. Rev Med Liège, 2005, 60, 566-571.
Philips J-C, Scheen AJ.- L'insulinothérapie dans le diabète de type 2. Rev Med Liège, 2005, 60, 419-423.
Turner RC, Cull CA, Frighi V, et al, for the UK Prospective Diabetes Study (UKPDS) Group.- Glycemic control with diet, sulphonylurea, metformin, or insulin in patients with type 2 diabetes mellitus. Progressive requirement for multiple therapies. JAMA, 1999, 28, 2005-2012.
Home P, Chacra A, Chan J, et al.- Worldwide Initiative for Diabetes Education. Considerations on blood glucose management in type 2 diabetes mellitus. Diabetes Metab Res Rev, 2002, 18, 273-285.